The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Abstract
A set of chemokine receptors are structurally unable to elicit migration or conventional signalling responses after ligand engagement. These 'silent' (non-signalling) chemokine receptors regulate inflammatory and immune reactions in different ways, including by acting as decoys and scavengers. Chemokine decoy receptors recognize distinct and complementary sets of ligands and are strategically expressed in different cellular contexts. Importantly, viruses and parasites have evolved multiple strategies to elude chemokines, including the expression of decoy receptors. So, decoy receptors for chemokines represent a general strategy to tune, shape and temper innate and adaptive immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As they persist in tissues, senescent cells likely create a proinflammatory tissue environment, which is known to be protumorigenic [ 3 , 64 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [64]
In the citing paper
“Actually, MCP1 and MUC5AC are responsible for inflammatory cells infiltration[37] and hypersecretion of mucus [38].”
Citations
Cites
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,633
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909.909_909_928 · Cited by 2,126
The Resistance Factor toPlasmodium vivaxin Blacks
Miller, L. H., Mason, S. J., CLYDE, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,259
The Molecular Biology of Leukocyte Chemoattractant Receptors
Murphy, P. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003113 · Cited by 1,197
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 979
Self-citationAnti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 917
Chemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature reviews. Immunology · doi:10.1038/nri722 · Cited by 755
Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells
Middleton, J., Neil, S. J. D., Wintle, J., Clark‐Lewis, I., Moore, H. D., Lam, C., Auer, M., Hub, E., & Rot, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80422-5 · Cited by 729
Research works printed but not linked: 1
- Rollins, B. J. Chemokines. Blood 90, 909–928 (1997). · DOI
Cited by
Sorted by citations
Items 101–200 of 480
Feng, L.-Y., Ou, Z.-L., Wu, F.-Y., Shen, Z., & Shao, Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2495 · Cited by 98
Trujillo, G., O'Connor, E. C., Kunkel, S. L., & Hogaboam, C. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070832 · Cited by 100
Effect of posttranslational processing on the in vitro and in vivo activity of chemokines
Mortier, A., Gouwy, M., Damme, J. V., & Proost, P. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.016 · Cited by 94
The Chemokine CXCL8 in Carcinogenesis and Drug Response
Gales, D. N., Clark, C. E., Manne, U., & Samuel, T. (2013) · ISRN Oncology · doi:10.1155/2013/859154 · Cited by 97
Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer
Lund, A. W., Medler, T. R., Leachman, S. A., & Coussens, L. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0023 · Cited by 97
Bondue, B., Vosters, O., de Nadai, P., Glineur, S., De Henau, O., Luangsay, S., Van Gool, F., Communi, D., De Vuyst, P., Desmecht, D., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002358 · Cited by 92
Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis
Raman, V. S., Bhatia, A., Picone, A. F., Whittle, J., Bailor, H. R., O’Donnell, J. A., Pattabhi, S., Guderian, J. A., Mohamath, R., Duthie, M. S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000238 · Cited by 92
The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage
Prete, A. D., Martínez‐Muñoz, L., Mazzon, C., Toffali, L., Sozio, F., Za, L., Bosisio, D., Gazzurelli, L., Salvi, V., Tiberio, L., et al. (2017) · Blood · doi:10.1182/blood-2017-04-777680 · Cited by 95
Self-citationTeoh, N. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06584.x · Cited by 92
Oshima, H., Nakayama, M., Han, T.-S., Naoi, K., Ju, X., Maeda, Y., Robine, S., Tsuchiya, K., Sato, T., Sato, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2036 · Cited by 92
Garrido, P., Shalaby, A. M., Walsh, E. M., Keane, N., Webber, M., Keane, M., Sullivan, F. J., Kerin, M. J., Callagy, G. M., Ryan, A. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19631 · Cited by 93
Cochain, C., Auvynet, C., Poupel, L., Vilar, J., Dumeau, E., Richart, A. L., Récalde, A., Zouggari, Y., Yin, K. Y. H. W., Bruneval, P., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.254409 · Cited by 93
Self-citationD6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion
Lee, K. M., McKimmie, C. S., Gilchrist, D. S., Pallas, K. J., Nibbs, R. J. B., Garside, P., McDonald, V., Jenkins, C. R., Ransohoff, R. M., Liu, L., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344044 · Cited by 89
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1
McKimmie, C. S., Fraser, A. R., Hansell, C. A. H., Gutiérrez, L., Philipsen, S., Connell, L. E., Rot, A., Kurowska‐Stolarska, M., Carreño, P., Pruenster, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8170-a · Cited by 86
Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation
Bonecchi, R., Borroni, E. M., Anselmo, A., Doni, A., Savino, B., Mirolo, M., Fabbri, M., Jala, V. R., Haribabu, B., Mantovani, A., et al. (2008) · Blood · doi:10.1182/blood-2007-08-108316 · Cited by 88
Self-citationBias in chemokine receptor signalling
Zweemer, A. J. M., Toraskar, J., Heitman, L. H., & IJzerman, A. P. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.004 · Cited by 87
Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer
Wu, F.-Y., Ou, Z.-L., Feng, L.-Y., Luo, J.-M., Wang, L.-P., Shen, Z., & Shao, Z.-M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2108 · Cited by 85
Comerford, I., Nibbs, R. J. B., Litchfield, W., Bunting, M. D., Harata‐Lee, Y., Haylock‐Jacobs, S., Forrow, S., Körner, H., & McColl, S. R. (2010) · Blood · doi:10.1182/blood-2010-01-264390 · Cited by 85
Chemokines and glioma: Invasion and more
Sciumè, G., Santoni, A., & Bernardini, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.019 · Cited by 84
Chemokine receptors intracellular trafficking
Borroni, E. M., Mantovani, A., Locati, M., & Bonecchi, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.006 · Cited by 86
Self-citationWermers, J. D., McNamee, E. N., Wurbel, M., Jedlicka, P., & Rivera–Nieves, J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.044 · Cited by 83
CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space
Vries, M. H. M., Wagenaar, A., Verbruggen, S. E. L., Molin, D. G. M., & Post, M. J. (2014) · Angiogenesis · doi:10.1007/s10456-014-9454-1 · Cited by 81
Hansell, C. A. H., Schiering, C., Kinstrie, R., Ford, L. B., Bordon, Y., McInnes, I. B., Goodyear, C. S., & Nibbs, R. J. B. (2011) · Blood · doi:10.1182/blood-2010-11-317115 · Cited by 81
An analysis of the function and expression of D6 on lymphatic endothelial cells
McKimmie, C. S., Singh, M. D., Hewit, K. D., López‐Franco, Ó., Brocq, M. L. L., Rose‐John, S., Lee, K. M., Baker, A. H., Wheat, R. L., Blackbourn, D. J., et al. (2013) · Blood · doi:10.1182/blood-2012-04-425314 · Cited by 82
An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue
Amisten, S., Neville, M. J., Hawkes, R. G., Persaud, S. J., Karpe, F., & Salehi, A. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.007 · Cited by 82
Atypical chemokine receptors in cancer: friends or foes?
Massara, M., Bonavita, O., Mantovani, A., Locati, M., & Bonecchi, R. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0915-431rr · Cited by 79
Self-citationHemopoietic Cell Expression of the Chemokine Decoy Receptor D6 Is Dynamic and Regulated by GATA1
McKimmie, C. S., Fraser, A. R., Hansell, C. A. H., Gutiérrez, L., Philipsen, S., Connell, L. E., Rot, A., Kurowska‐Stolarska, M., Carreño, P., Pruenster, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3353 · Cited by 78
Transcriptional diversity during monocyte to macrophage differentiation
Liu, H., Shi, B., Huang, C., Eksarko, P., & Pope, R. M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.12.012 · Cited by 78
Liu, Z., Zhu, Y., Xu, L., Zhang, J., Xie, H., Fu, H., Zhou, Q., Chang, Y., Dai, B., & Xu, J. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1474317 · Cited by 75
Borroni, E. M., Cancellieri, C., Vacchini, A., Bénureau, Y., Lagane, B., Bachelerie, F., Arenzana‐Seisdedos, F., Mizuno, K., Mantovani, A., Bonecchi, R., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003627 · Cited by 77
Self-citationLee, W.-B., Choi, W. Y., Lee, D.-H., Shim, H., Kim-Ha, J., & Kim, Y.-J. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.2.129 · Cited by 64
“Next, we evaluated CCL2, CCL8, and CXCL10 secretion in response to type I IFNs, and the levels of these chemokines were also similar among WT, OAS1−/−, and OAS3−/− dTHP-1 cells after stimulation with IFN(Supplementary Fig.”
BackgroundInfluentialCCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
Pervaiz, A., Zepp, M., Mahmood, S., Ali, D. M., Berger, M. R., & Adwan, H. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0415-3 · Cited by 73
Jensen, S. S., & Gad, M. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-37 · Cited by 72
de Oliveira, J. G., Rossi, A. F. T., Nizato, D. M., Cadamuro, A. C. T., Jorge, Y. C., Valsechi, M. C., Venâncio, L. P. R., Rahal, P., Pavarino, É. C., Goloni‐Bertollo, E. M., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3593-x · Cited by 73
Verleden, S. E., Ruttens, D., Vos, R., Vandermeulen, E., Moelants, E. A. V., Mortier, A., Raemdonck, D. E. V., Proost, P., Schols, D., Verleden, G. M., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000269 · Cited by 69
Finlay, D. B., Joseph, W. R., Grimsey, N. L., & Glass, M. (2016) · PeerJ · doi:10.7717/peerj.1835 · Cited by 74
CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM‐B
Leick, M., Catusse, J., Follo, M., Nibbs, R. J. B., Hartmann, T. N., Veelken, H., & Burger, M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03209.x · Cited by 68
Ben‐Baruch, A. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0094-3 · Cited by 69
CXC chemokine signaling in the liver: Impact on repair and regeneration
Sweringen, H. L. V., Sakai, N., Tevar, A. D., Burns, J. M., Edwards, M. J., & Lentsch, A. B. (2011) · Hepatology · doi:10.1002/hep.24457 · Cited by 68
A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration
Lau, S., Feitzinger, A. A., Venkiteswaran, G., Wang, J., Lewellis, S. W., Koplinski, C. A., Peterson, F. C., Volkman, B. F., Meier‐Schellersheim, M., & Knaut, H. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0465-4 · Cited by 67
Hypoxia: a double-edged sword of immunity
Sica, A., Melillo, G., & Varesio, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0724-8 · Cited by 66
Multiple Roles for the C-terminal Tail of the Chemokine Scavenger D6
McCulloch, C. V., Morrow, V. A., Milasta, S., Comerford, I., Milligan, G., Graham, G. J., Isaacs, N. W., & Nibbs, R. J. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710128200 · Cited by 65
Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications
Hirosue, S., & Dubrot, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00446 · Cited by 70
Horton, L. W., Yu, Y., Zaja‐Milatovic, S., Strieter, R. M., & Richmond, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0246 · Cited by 64
Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6
Graham, G. J., & Locati, M. (2012) · The Journal of Pathology · doi:10.1002/path.4123 · Cited by 65
Self-citationMahabaleshwar, H., Boldajipour, B. A., & Raz, E. (2008) · Cell Adhesion & Migration · doi:10.4161/cam.2.2.6027 · Cited by 63
Inflammatory molecules: A target for treatment of systemic autoimmune diseases
Tincani, A., Andréoli, L., Bazzani, C., Bosisio, D., & Sozzani, S. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.03.001 · Cited by 63
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa
van Straalen, K. R., Ma, F., Tsou, P., Plazyo, O., Gharaee‐Kermani, M., Calbet, M., Xing, X., Sarkar, M. K., Uppala, R., Harms, P. W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169225 · Cited by 65
Altered profile of chemokines in fibromyalgia patients
García, J. J., Cidoncha, A., Bote, E., Hinchado, M. D., & Ortega, E. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213506413 · Cited by 62
Joven, J., Rull, A., Rodríguez‐Gallego, E., Camps, J., Riera-Borrull, M., Hernández‐Aguilera, A., Martín-Paredero, V., Segura‐Carretero, A., Micol, V., Alonso‐Villaverde, C., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.004 · Cited by 65
Finding their niche: chemokines directing cell migration in the thymus
Bunting, M. D., Comerford, I., & McColl, S. R. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.142 · Cited by 59
Overview and potential unifying themes of the atypical chemokine receptor family
Vacchini, A., Locati, M., & Borroni, E. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr1015-477r · Cited by 59
Self-citationOverexpression of CXCL3 can enhance the oncogenic potential of prostate cancer
Gui, S.-L., Teng, L. L., Wang, S., Liu, S., Lin, Y.-L., Zhao, X., Liu, L., Sui, H., Yang, Y., Liang, L., et al. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1222-2 · Cited by 59
Attractive guidance: How the chemokine SDF1/CXCL12 guides different cells to different locations
Lewellis, S. W., & Knaut, H. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.03.009 · Cited by 58
Mortier, A., Loos, T., Gouwy, M., Ronsse, I., Damme, J. V., & Proost, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119388 · Cited by 58
Chemokine Decoy Receptors: Structure–Function and Biological Properties
Bonecchi, R., Savino, B., Borroni, E. M., Mantovani, A., & Locati, M. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_19 · Cited by 58
Self-citationChemokines and their receptors: orchestrating a fine balance between health and disease
Sharma, M. (2009) · Critical Reviews in Biotechnology · doi:10.1080/07388550903187418 · Cited by 65
Loos, T., Opdenakker, G., Damme, J. V., & Proost, P. (2009) · Haematologica · doi:10.3324/haematol.2009.006973 · Cited by 57
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
Baram, T., Rubinstein-Achiasaf, L., Ben-Yaakov, H., & Ben‐Baruch, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.614468 · Cited by 61
Madigan, J., Freeman, D. J., Menzies, F. M., Forrow, S., Nelson, S. M., Young, A., Sharkey, A., Moffett, A., Graham, G. J., Greer, I. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902118 · Cited by 54
Foxm1 Regulates Resolution of Hyperoxic Lung Injury in Newborns
Xia, H., Ren, X., Bolte, C., Ustiyan, V., Zhang, Y., Shah, T. A., Kalin, T. V., Whitsett, J. A., & Kalinichenko, V. V. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0091oc · Cited by 55
G protein-coupled receptors as therapeutic targets for multiple sclerosis
Du, C., & Xie, X. (2012) · Cell Research · doi:10.1038/cr.2012.87 · Cited by 56
Chaves-Pozo, E., Montero, J., Cuesta, A., & Tafalla, C. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.01.009 · Cited by 54
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation
Bonecchi, R., Garlanda, C., Mantovani, A., & Riva, F. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.023 · Cited by 54
Self-citationLeyva-Baca, I., Schenkel, F. S., Martin, J., & Karrow, N. A. (2007) · Journal of Dairy Science · doi:10.3168/jds.2007-0142 · Cited by 55
CXC chemokines play a critical role in liver injury, recovery, and regeneration
Clarke, C. N., Kuboki, S., Tevar, A. D., Lentsch, A. B., & Edwards, M. (2009) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.01.025 · Cited by 53
Savino, B., Borroni, E. M., Torres, N. M., Proost, P., Struyf, S., Mortier, A., Mantovani, A., Locati, M., & Bonecchi, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029249 · Cited by 51
Self-citationAuguet, T., Bertran, L., Binetti, J., Aguilar, C., Martínez, S., Sabench, F., Lopez-Dupla, J. M., Porras, J. A., Riesco, D., Castillo, D. D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114189 · Cited by 52
Chemokine patterning by glycosaminoglycans and interceptors
Rot, A. (2009) · Frontiers in bioscience · doi:10.2741/3638 · Cited by 50
Enhancement of Chemokine Function as an Immunomodulatory Strategy Employed by Human Herpesviruses
Viejo‐Borbolla, A., Martinez-Martín, N., Nel, H. J., Rueda, P., Martín, R., Blanco, S., Arenzana‐Seisdedos, F., Thelen, M., Fallon, P. G., & Alcamı́, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002497 · Cited by 51
Cittera, E., Leidi, M., Buracchi, C., Pasqualini, F., Sozzani, S., Vecchi, A., Waterfield, J. D., Introna, M., & Golay, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6616 · Cited by 51
The Atypical Chemokine Receptor D6 Contributes to the Development of Experimental Colitis
Bordon, Y., Hansell, C. A. H., Sester, D. P., Clarke, M., Mowat, A. M., & Nibbs, R. J. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802802 · Cited by 50
Montero, J., Chaves-Pozo, E., Cuesta, A., & Tafalla, C. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.08.003 · Cited by 50
Xu, J., Shen, C., Lin, W., Meng, T., Ooi, J. D., Eggenhuizen, P. J., Tang, R., Xiao, G., Jin, P., Ding, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683330 · Cited by 50
DARC and D6: silent partners in chemokine regulation?
Hansell, C. A. H., Hurson, C. E., & Nibbs, R. J. B. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.147 · Cited by 50
Cord immunoproteins as predictors of respiratory outcome in preterm infants
Kaukola, T., Tuimala, J., Herva, R., Kingsmore, S. F., & Hallman, M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.07.070 · Cited by 49
O’Loughlin, A., Lynn, D. J., McGee, M., Doyle, S., McCabe, M. S., & Earley, B. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-250 · Cited by 49
An unexpected player in Gaucher disease: The multiple roles of complement in disease development
Pandey, M. K., Grabowski, G. A., & Köhl, J. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.006 · Cited by 49
CXCL10+ peripheral activation niches couple preferred sites of Th1 entry with optimal APC encounter
Prizant, H., Patil, N., Negatu, S. G., Bala, N., McGurk, A. I., Leddon, S. A., Hughson, A. L., McRae, T. D., Gao, Y., Livingstone, A. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109523 · Cited by 44
Human intestinal mast cells are a potent source of multiple chemokines
Feuser, K., Thon, K., Bischoff, S. C., & Lorentz, A. (2012) · Cytokine · doi:10.1016/j.cyto.2012.01.001 · Cited by 49
Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site.
Katzman, S. D., & Fowell, D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33174 · Cited by 53
Singh, M. D., King, V., Baldwin, H., Burden, A. D., Thorrat, A., Holmes, S., McInnes, I. B., Nicoll, R., Shams, K., Pallas, K. J., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.042 · Cited by 47
CCR7 Signaling Inhibits T Cell Proliferation
Ziegler, E., Oberbarnscheidt, M. H., Bulfone‐Paus, S., Förster, R., Kunzendorf, U., & Krautwald, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6485 · Cited by 47
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease
Magnusen, A. F., Hatton, S. L., Rani, R., & Pandey, M. K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.636139 · Cited by 47
Immune modulation by virus-encoded secreted chemokine binding proteins
Heidarieh, H., Hernáez, B., & Alcamı́, A. (2015) · Virus Research · doi:10.1016/j.virusres.2015.02.028 · Cited by 47
CCRL 2, a fringe member of the atypical chemoattractant receptor family
Prete, A. D., Bonecchi, R., Vecchi, A., Mantovani, A., & Sozzani, S. (2013) · European Journal of Immunology · doi:10.1002/eji.201243179 · Cited by 45
Self-citationSexual dimorphisms in leukocyte trafficking in a mouse peritonitis model
Kay, E., Gómez-García, L., Woodfin, A., Scotland, R. S., & Whiteford, J. R. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1214-601rr · Cited by 46
Expression of the Atypical Chemokine Receptor D6 in Human Alveolar Macrophages in COPD
Bazzan, E., Saetta, M. P., Turato, G., Borroni, E. M., Cancellieri, C., Baraldo, S., Savino, B., Calabrese, F., Ballarin, A., Balestro, E., et al. (2013) · CHEST Journal · doi:10.1378/chest.11-3220 · Cited by 45
Self-citationCytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?
Chizzolini, C., Dayer, J., & Miossec, P. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2767 · Cited by 47
Advances in the Pathogenesis of Cardiorenal Syndrome Type 3
Clementi, A., Virzì, G. M., Brocca, A., de Cal, M., Pastori, S., Clementi, M., Granata, A. R. M., Vescovo, G., & Ronco, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/148082 · Cited by 44
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Torphy, R. J., Sun, Y., Lin, R., Caffrey-Carr, A. K., Fujiwara, Y., Ho, F., Miller, E. N., McCarter, M. D., Lyons, T. R., Schulick, R. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27658-x · Cited by 44
Abdi, A. I., Carvalho, T. G., Wilkes, J., & Doerig, C. (2013) · Microbiology · doi:10.1099/mic.0.070409-0 · Cited by 43
Klepacki, H., Kowalczuk, K., Łepkowska, N., & Hermanowicz, J. M. (2025) · Cells · doi:10.3390/cells14130942 · Cited by 49
The Role of Chemokines in Thyroid Carcinoma
Yapa, S., Mulla, O., Green, V., England, J. A., & Greenman, J. (2017) · Thyroid · doi:10.1089/thy.2016.0660 · Cited by 43
Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
Russo, R. C., Garcia, C. C., & Teixeira, M. M. (2010) · PubMed · Cited by 43
Immune Signatures Predict Prognosis in Localized Cancer
Hsu, D. S., Kim, M. K., Balakumaran, B. S., Acharya, C. R., Anders, C. K., Clay, T. M., Lyerly, H. K., Drake, C. G., Morse, M. A., & Febbo, P. G. (2010) · Cancer Investigation · doi:10.3109/07357900903095755 · Cited by 43
Mehrpouri, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174831 · Cited by 42
Xue, X., Lu, Q., Wei, H., Wang, D., Chen, D., He, G., Huang, L., Wang, H., & Wang, X. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002162 · Cited by 42
Savino, B., Caronni, N., Anselmo, A., Pasqualini, F., Borroni, E. M., Basso, G., Celesti, G., Laghi, L., Tourlaki, A., Boneschi, V., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0202 · Cited by 44
Self-citationChan, C., Lee, K., Huang, Y., Chou, C., Lin, H., & Lee, F. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12366 · Cited by 41
Metadata
- Authors
- Mantovani, A., Bonecchi, R., & Locati, M.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Mantovani, Alberto
- Venue
- Nature Reviews Immunology
- Published
- 2006-12-01
- Volume
- 6
- Issue
- 12
- Pages
- 907-918
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970170374
- Cited by
- 481
- References
- 106
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 8 · 2023: 14 · 2022: 16 · 2021: 21 · 2020: 22 · 2019: 17 · 2018: 21 · 2017: 27 · 2016: 22 · 2015: 29 · 2014: 24 · 2013: 39 · 2012: 39
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero della Salute
- Ministero dell'Università e della Ricerca
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- chemokine receptors, leukocyte recruitment, inflammation regulation, immunomodulation, parasite evasion, innate immunity, adaptive immunity
- MeSH terms
- Animals, Cell Movement, Immunity, Inflammation, Parasites, Protein Conformation, Viruses, Chemokines, Receptors, Chemokine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review